Mounjaro and Anaesthesia: What Your Surgical Team Needs to Know

Step 1, Tell your surgical team well before the procedure date

The conversation needs to happen early, not the morning of the operation. When you are listed for any procedure requiring anaesthesia, let the surgeon's team know you are taking tirzepatide at your pre-assessment appointment. The anaesthetist will factor it into your fasting instructions and induction plan. If you have had a pre-assessment and then started Mounjaro afterwards, contact the team again, do not wait for them to ask.

This applies to elective procedures, day-case surgery, dental procedures under sedation, and emergency situations where time allows. General anaesthesia carries the highest gastric-emptying concern, but your team may also want to know for deeper sedation. When in doubt, mention it regardless of the procedure type.

The same principle applies if you are still working through the starting weeks of treatment, the pharmacokinetics of tirzepatide mean it continues to slow gastric motility for some time after a dose, so the conversation is relevant throughout treatment, not just at higher doses.

Step 2, Understand what the clinical concern actually is

Mounjaro is a dual GIP and GLP-1 receptor agonist. Among its mechanisms, it reduces the rate at which the stomach empties, an effect that contributes to reduced appetite and earlier satiety, and that is part of how the medicine works. Under anaesthesia, a stomach that empties more slowly than usual carries a greater risk of regurgitation: stomach contents entering the airway during induction or recovery, a complication called pulmonary aspiration.

Standard pre-operative fasting guidance is designed around typical gastric emptying times. Because tirzepatide can extend those times, anaesthetic guidelines for patients on GLP-1 and dual-agonist medicines are evolving. Some anaesthetists will recommend a longer clear-fluid fast or adjust their induction approach; others may request an ultrasound assessment of gastric contents before proceeding. These are clinical judgements, not rules that a pharmacy can set for you.

It is worth knowing that the evidence base here is still developing. Most guidance issued to date draws on the pharmacology of the drug class and case reports rather than large prospective trials. That is precisely why the recommendation is to have the conversation rather than follow a fixed protocol. Anaesthesia considerations for Mounjaro are covered in more depth if you want to read the clinical background before your appointment.

Step 3, Ask your prescriber whether to pause treatment before surgery

Some surgical teams will ask patients to hold their Mounjaro dose for one to two weeks before a planned procedure to allow gastric motility to normalise closer to baseline. Others will not, particularly for shorter procedures or where pausing creates a meaningful metabolic risk. This is not a decision you should make on your own, and it is not one a pharmacy can make for you either.

If you receive your Mounjaro through nume, contact our prescribing team as soon as you have a surgery date, they can liaise on your behalf and confirm the clinical position on your record. You can reach the team through our contact page. Because our prescribers review every repeat order individually, any note about a planned procedure will be factored into your next clinical review. The 12pm same-day dispatch cut-off means you will not be left waiting for a response on working days.

Do not simply skip a dose without telling anyone. An unplanned gap in treatment without clinical oversight can affect blood-glucose management in patients who also have type 2 diabetes, and it removes information the surgical team needs. If you are wondering how Mounjaro affects the liver, including what that means for your broader metabolic health during a treatment pause, that background is worth reading before your pre-assessment. Communication in both directions (to your surgeon and to your prescriber) is the safest path.

Step 4, After surgery: restarting Mounjaro

Once you are recovering, the question of when to restart Mounjaro should go to your prescriber, not be decided by looking at your usual schedule. Post-operative nausea is common, and the GI side effects of tirzepatide can compound it. There may also be changes to oral intake, hydration and other medicines in the days after surgery that affect whether restarting immediately is appropriate.

Your prescriber will want to know the procedure went ahead, how your recovery is progressing, and whether you are tolerating food and fluids again before confirming it is the right time to re-dose. The Mounjaro aftercare support available through our team operates seven days a week, so you are not left guessing over a weekend. If you experience any unexpected symptoms during recovery (severe stomach pain that extends to the back, signs of dehydration, or anything that feels urgent) seek medical attention through your surgical team or 111; do not wait for a pharmacy review. It is also sensible to read up on how Mounjaro interacts with local anaesthesia if any follow-up procedures, such as wound care or minor dental work, are planned during your recovery period.

For anyone considering Mounjaro for weight management more broadly, you can explore the treatment options available at nume to understand whether it might suit your situation ahead of any clinical assessment.